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Introduction
The pediatric lupus patients are required to meet the
American College of Rheumatology (ACR) minimum
criteria to be included in the research cohort and con-
sidered for aggressive therapy. This approach may delay
early aggressive therapy.
Objectives
The research explores whether by delaying diagnosis
until 4/11 criteria are met affects the patient outcome
negatively. To our knowledge there is no published lit-
erature of the “probable” pediatric systemic lupus
erythematosus (pSLE) population.
Method
Institutional Review Board approval was obtained to retro-
spectively review the charts of 98 SLE patients seen in the
pediatric rheumatology clinic at Nationwide Children’s
Hospital over the past 24 years. All the patients were
divided in to two groups, ‘definitive pSLE’ - who met the
minimum 4/11, or more ACR criteria and the ‘probable
pSLE’ who did not meet the minimum criteria at presenta-
tion in rheumatology clinic. Both the groups were assessed
for disease severity, damage and gradient of damage.
Appropriate statistical tests were used i.e. Chi-Square test,
Fisher’s Exact test, Univariate logistic regression and
Wilcoxon two-sample test were used for statistics for var-
ious data set. All tests were conducted in SAS 9.2
Results
Out of 98 pSLE patients 71% were included in definitive
pSLE (D pSLE) group while 28.57% were included in
probable pSLE (P pSLE) group.The mean time for
PpSLE group to reach D pSLE status was 20.3 months.
There was no difference in the ethnic distribution (p =
0.7370) in D pSLE and PpSLE. PpSLE were more likely
to have higher male: female ratio (p = 0.032), and were
older at presentation that D pSLE (p = 0.045).PpSLE
patients were less likely to have internal organ involve-
ment (7.1% Vs 25.7%), were less likely to be hospitalized
and receive pulse steroids (p = 0.0142) or oral steroids
(0.0172) at presentation. PpSLE patients were less likely
to be hospitalized receive pulse steroids ever (p =
0.0628), were less likely to have renal disease ever (p =
0.0653) and nervous system disease ever (p = 0.0182).
Probable SLE was more likely to receive hydroxychloro-
quine (p = 0.050).The organ damage was assessed using
SLICC/ACR damage index at 1, 5 and 10 years post
diagnosis. The maximum damage was recorded within
first 5 years of the diagnosis. Initial damage was predic-
tive of later damage. D pSLE had higher disease damage
scores at 5 and 10 years We compared the gradient
between the onsets of symptoms and the development
of organ damage in the two groups. The PpSLE patients
had significantly higher internal organ damage gradient
as compared to D pSLE (p value = 0.0169)
Conclusion
In our population PpSLE patients had a significantly high
gradient of damage than the D pSLE group.In spite of D
pSLE being more severe diseases ever and more diseases
damage, the disease damage progression was steeper and
faster in PpSLE. This can only be explained by the fact
that PpSLE patients received less intense treatment at
presentation than D pSLE group. It may be that PpSLE
patients at presentation need just as vigorous treatment
as the children with definitive SLE
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